This result agrees with previous studies observing a CD4+ T-cell driven SLE pathogenesis [17]; thus, we can suppose that CD137 overexpression may contribute to the persistent activation of adaptive immune response by perpetuating costimulation signaling. The gene discussed is TNFRSF9; the disease is systemic lupus erythematosus.